Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

The US government plans to make more at-home Covid-19 tests available for free this month as the country heads into ...

COVID-19 numbers are on the rise in the N.W.T., with 54 known cases counted between June and August this year. That's four ...

The U.S. government plans to make more at-home COVID-19 tests available for free this month as the country heads into ...

According to Suyama, in 2023 the flu killed 44,000 people nationwide, while COVID killed 74,000 people. “So COVID was nearly ...

The latest trading session saw Novavax (NVAX) ending at $12.80, denoting a -0.85% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily gain of 0.28%. Meanwhile ...